Hematology NewsNew gene variant found for hereditary bleeding disorderSeptember 8, 2021Bleeding Disorders
Hematology NewsInfusion shown effective for acquired von Willebrand diseaseAugust 10, 2021Bleeding Disorders
Hematology NewsRecombinant factor IX fusion protein benefited untreated patients with hemophilia BAugust 4, 2021Bleeding Disorders
Hematology NewsBleeding events tied to higher mortality in patients with factor V inhibitionJuly 7, 2021Bleeding Disorders
Hematology NewsNovel molecule prolongs half-life of bleeding disorder treatmentsJune 23, 2021Bleeding Disorders
Hematology NewsFirst year of life sees initial bleeding episodes in children with von Willebrand diseaseJune 9, 2021Bleeding DisordersPediatrics
Hematology NewsElevated factor VIII troughs can lead to a higher proportion of zero bleeds in hemophiliaJune 1, 2021Bleeding Disorders
Hematology NewsMedical homes a boon to patients with bleeding disordersMay 20, 2021Bleeding DisordersPreventive Care
Hematology NewsFDA approves new treatment option for rare anemiaMay 18, 2021AnemiaThrombosisBleeding Disorders
Hematology NewsHealth costs over 25 times higher for hemophilia B patients than controlsMay 11, 2021Bleeding Disorders
Hematology NewsHigh variability found in studies assessing hemophilia-related painMay 4, 2021Bleeding Disorders
Hematology NewsReal-world outcomes of caplacizumab for iTTP comparable to clinical trial resultsApril 7, 2021Bleeding Disorders
Hematology NewsClose joint health monitoring essential with new hemophilia therapiesMarch 12, 2021Bleeding DisordersMixed Topics
Hematology NewsJoint pain in patients with hemophilia may be neuropathicMarch 10, 2021Bleeding Disorders
Hematology NewsType 3 von Willebrand a rare but serious bleeding disorderMarch 10, 2021Bleeding Disorders
